As of the latest SEC filings, GT Biopharma, Inc. (GTBP) is held by 5 institutional funds. The largest fund shareholder is VANGUARD EXTENDED MARKET INDEX FUND (VEMPX), holding an estimated $184,410.19 in market value, representing a significant portion of its portfolio.
Funds holding GT Biopharma, Inc. (GTBP)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- GTBP
- CIK:
- 0000109657
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $184,410.19 | 451,875 | Mar 31, 2026 | May 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $10,445.26 | 21,852 | Feb 28, 2026 | Apr 24, 2026 |
|
FCFMX
Fidelity Series Total Market Index Fund
|
MF | Fidelity | 0.00% | $1,701.20 | 3,559 | Feb 28, 2026 | Apr 24, 2026 |
|
FSKAX
Fidelity Total Market Index Fund
|
MF | Fidelity | 0.00% | $1,049.69 | 2,196 | Feb 28, 2026 | Apr 24, 2026 |
|
GUG
Guggenheim Active Allocation Fund
|
CEF | Guggenheim | 0.00% | $1.43 | 3 | Feb 27, 2026 | Apr 29, 2026 |
Advertisement (320x50)